Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Matoda, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1159-3.
Published August 12, 2026 · Recall initiated: August 5, 2026
Summary
FDA records drug Class II recall D-0745-2026, published August 12, 2026 and initiated August 5, 2026. Recalling firm: Zydus Pharmaceuticals (USA) Inc; Status: Ongoing; Lot: Lot # E408618, Expiry: 11/30/2026, NDC #: 70710-1159-3. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.
What to do
Voluntary: Firm initiated · Letter
Get an email if MIRABEGRON has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- MIRABEGRON
- Manufacturer
- Zydus Pharmaceuticals (USA) Inc
- Distributor
- Nationwide in the USA
- Lot
- Lot # E408618, Expiry: 11/30/2026, NDC #: 70710-1159-3
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACyclophosphamide for Injection, USP, 2 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long GroveAugust 12, 2026
- FDASpicy Breakfast Burrito sold under the following brand names: FRESH & READY FOODS Spicy Breakfast Burrito NetAugust 12, 2026
- FDACyclophosphamide for Injection, USP, 1 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long GroveAugust 12, 2026
- FDAFlexible food pouch (3-layer foil, spouted, #CP6088), manufactured for packaging Pumpkin Tree Peter RabbitAugust 12, 2026
- FDATotal Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, (patient specific), Compound Volume 416.8 mLAugust 12, 2026
- FDA"***Hondashi 0.25oz***" seasoning packed in silver plastic/metallic pouch, pouches packed in brown paperboardAugust 12, 2026
Questions about this recall
Was Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Matoda, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1159-3. recalled?
Yes. FDA published recall D-0745-2026 on August 12, 2026. Reported hazard: CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: MIRABEGRON.